Published by Frank Prenesti on 22nd November 2022
(Sharecast News) - British pharmaceutical giant GSK on Tuesday said it has started proceedings to pull US approval for its blood cancer drug Blenrep after it failed to meet the requirements of a late-stage trial.
URL: http://www.digitallook.com/dl/news/story/33125686/...